Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000138

Director sold 1,032 shares at an average $80.26 ($82,833)

  • Director acquired 1,032 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LOSCALZO JOSEPH · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form 10b5-1 +832 $38.06 $31,666 37,162 D
2026-03-03 Sale : show line 2 in the form 10b5-1 −832 $80.33 $66,833 36,330 D
2026-03-04 Exercise or conversion : show line 3 in the form 10b5-1 +200 $38.06 $7,612 36,530 D
2026-03-04 Sale : show line 4 in the form 10b5-1 −200 $80.00 $16,000 36,330 D
Open-market sales · 1,032 sh · avg $80.26 · $82,833

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-03 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −832 11,168 D
2026-03-04 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −200 10,968 D
Loading xslF345X05/edgardoc.xml…